#Osa

GLP-1 receptor agonists reduce sleep apnea severity by 14 events per hour

A 2026 meta-analysis of four randomized controlled trials finds that GLP-1 receptor agonists reduce the apnea-hypopnea index by 13.9 events per hour, lower body weight by 12.5 kg, and improve blood pressure in patients with obstructive sleep apnea and obesity.